Companies: 10,795·Total market cap: $144.5T
Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRXNASDAQHealthcare
$1.51
+$0.05(+3.42%)
Market Cap$10425795
P/E Ratio
52W High$2.63
52W Low$0.2
Overview

Agile Therapeutics, Inc. (AGRX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · AGRX · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-3.23agrx eps ttm · agrx earnings per shareEarnings history
PE Ratio (TTM)agrx pe ratio ttm · agrx price to earningsPE Ratio deep dive
Revenue (TTM)$21.6Magrx revenue ttm · agrx annual revenueFull revenue history
Dividend YieldNo Dividenddoes agrx pay dividends · agrx dividend yieldDividend history
Shares Outstanding2.2Magrx shares outstanding · agrx floatShares outstanding history
Next EarningsTBAagrx earnings date · agrx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2023Revenue$19.6M▲ +80.02% YoY
202120222023
agile therapeutics, inc. revenue · agrx revenue 2023
FY 2023Net Income-$14.5M▲ +43.08% YoY
202120222023
agile therapeutics, inc. net income · agrx profit 2023
FY 2023EPS$-6.71▲ +88.59% YoY
202120222023
agrx eps · agile therapeutics, inc. earnings per share 2023
TTM:Revenue: $21.6MNet Income: -$15.9MEPS: $-3.23View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy10 analystsis agrx a buy · agrx analyst rating
Strong Buy
0
Buy
9
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$1.00Low
$1.51Current
$1.00Avg Target33.77% downside
$1.00High
agrx price target · agrx 12 month forecast

Total: 10 · Buy rate: 90.0%

The AGRX analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $1.00, representing -33.77% downside from the current price of $1.51.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+3.62%
3M+376.34%
YTD-17.93%
1Y-12.72%
5Y-99.93%

About Agile Therapeutics, Inc.

CEOAlfred F. Altomari
IPO DateMay 23, 2014
Employees19
CountryUS

Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship pr…

what is agile therapeutics, inc. · agrx stock overview · agile therapeutics, inc. company profile · who is agile therapeutics, inc. ceo · agrx NASDAQ · agile therapeutics, inc. headquarters · agile therapeutics, inc. business segments

About Stock Overview & Key Data

Agile Therapeutics, Inc. (AGRX) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since May 23, 2014. As of the latest trading session, AGRX stock price is $1.51, with a market capitalization of $10.4M. The stock has returned -12.72% over the past 12 months and -17.93% year-to-date.

According to 10 Wall Street analysts, the consensus rating for Agile Therapeutics, Inc. stock is Buy, with an average 12-month price target of $1.00. In fiscal year 2023, Agile Therapeutics, Inc. reported revenue of $19.6M and net income of -$14.5M. For detailed data — including Agile Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Agile Therapeutics, Inc. (AGRX) stock price is $1.51. The stock is traded on NASDAQ under the ticker symbol AGRX. The 52-week range is $0.20 – $2.63.

AGRX stock priceAGRX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice